ArticleAnnals of internal medicine2018

Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.

Neda Laiteerapong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.